An exemplary apparatus, can include, for example, a circulating tumor cell (CTC) treatment arrangement, a pump arrangement configured to circulate a fluid through the CTC treatment arrangement, and an electric field generator electrically connected to the CTC treatment arrangement, and configured to apply an electric field to the fluid circulating through the CTC treatment arrangement. The pump arrangement can be a peristaltic pump, which can be configured to continuously circulate the fluid through the CTC treatment arrangement. According to another exemplary embodiment of the present disclosure, method, system and computer-accessible medium can be provided for killing at least one circulating tumor cell (CTC). Using such exemplary embodiment, blood can be pumped from a body of a patient to an electroporation chamber inside of a CTC treatment arrangement. An electric field can be applied to the blood located in the electroporation chamber in order to kill the CTC. The electric field-applied blood can be pumped back into the body.

A method is provided for the real time calibration of a pump that is part of a reusable hardware component having a programmable controller during a blood separation procedure where fluid is flowed through a tubing in a tubing set by action of the pump. The method comprises programming the controller with a continuous function defining a relationship between pump inlet pressure and pump stroke volume; commencing the fluid processing procedure to operate the pump to draw fluid through the tubing; measuring fluid pressure in the tubing at the inlet of the pump; calculating a current pump stroke volume with the controller based on the continuous function and the pump rotational rate; and adjusting the pump rotational rate utilized by the controller to control the procedure to achieve a target fluid flow rate. The continuous function defining the relationship between pump inlet pressure and the pump stroke volume may be empirically determined over a predetermined range of inlet pressures.

Systems, devices and methods for treating lymphatic congestion are disclosed. In one method, a balloon is placed at or near the veno-lymph junction. The balloon is inflated and deflation through cycles of slow inflation and rapid deflation. In another embodiment, an arteriovenous fistula is created near the veno-lymph junction. Alternate embodiments may also include axial pumps, stents, or balloons in combination with the fistula. These devices and methods create an acceleration of the blood flow past the lymphatic duct which reduces local pressure via the Venturi effect and according to the Bernoulli principle which facilitates lymph entering into the bloodstream.

Devices can be used to detect a level of a fluid in a medical fluid reservoir. Methods for controlling the flow rate of a medical pump, and/or the occlusion amount of a medical fluid tube, that are based on the detected level of fluid in the medical reservoir can be used in a clinical setting.

The present invention relates to various methods of treatment using a novel blood perfusion device. The blood perfusion device comprises a perfusion chamber comprising at least one compartment A and at least one compartment B, compartment A comprising a first opening which is in direct fluid communication to a second opening, wherein the first opening of compartment A is in direct fluid communication to a first port of the perfusion chamber and the second opening of compartment A is in direct fluid communication to a second port of the perfusion chamber; and compartment B comprising a first opening which is in direct fluid communication to a second opening, wherein the first opening of compartment B is in direct fluid communication to a third port of the perfusion chamber and the second opening of compartment B is in direct fluid communication to a fourth port of the perfusion chamber, wherein compartment A is separated from compartment B by at least one membrane, said membrane being configured to prevent cells from crossing the membrane.

The present invention relates to various methods of treatment using a novel blood perfusion device. The blood perfusion device comprises a perfusion chamber comprising at least one compartment A and at least one compartment B, compartment A comprising a first opening which is in direct fluid communication to a second opening, wherein the first opening of compartment A is in direct fluid communication to a first port of the perfusion chamber and the second opening of compartment A is in direct fluid communication to a second port of the perfusion chamber; and compartment B comprising a first opening which is in direct fluid communication to a second opening, wherein the first opening of compartment B is in direct fluid communication to a third port of the perfusion chamber and the second opening of compartment B is in direct fluid communication to a fourth port of the perfusion chamber, wherein compartment A is separated from compartment B by at least one membrane, said membrane being configured to prevent cells from crossing the membrane.

A cardiac pump is arranged to mimic triphasic operation. The pump uses a fluid line formed from flexible tubing, along with a reciprocating actuator arranged to move between a free orientation and an occluding orientation. This allows a portion of the fluid line to be selectively occluded during movement of the actuator, enabling blood or other fluids to be peristaltically forced fluid towards a fluid outlet. The direction of operation of the actuator, and the selection of appropriate occluding or free orientations, allows the pump to be operated in a triphasic manner.

A cardiac pump is arranged to mimic triphasic operation. The pump uses a fluid line formed from flexible tubing, along with a reciprocating actuator arranged to move between a free orientation and an occluding orientation. This allows a portion of the fluid line to be selectively occluded during movement of the actuator, enabling blood or other fluids to be peristaltically forced fluid towards a fluid outlet. The direction of operation of the actuator, and the selection of appropriate occluding or free orientations, allows the pump to be operated in a triphasic manner.

A cardiac pump is arranged to mimic triphasic operation. The pump uses a fluid line formed from flexible tubing, along with a reciprocating actuator arranged to move between a free orientation and an occluding orientation. This allows a portion of the fluid line to be selectively occluded during movement of the actuator, enabling blood or other fluids to be peristaltically forced fluid towards a fluid outlet. The direction of operation of the actuator, and the selection of appropriate occluding or free orientations, allows the pump to be operated in a triphasic manner.

A cardiac pump is arranged to mimic triphasic operation. The pump uses a fluid line formed from flexible tubing, along with a reciprocating actuator arranged to move between a free orientation and an occluding orientation. This allows a portion of the fluid line to be selectively occluded during movement of the actuator, enabling blood or other fluids to be peristaltically forced fluid towards a fluid outlet. The direction of operation of the actuator, and the selection of appropriate occluding or free orientations, allows the pump to be operated in a triphasic manner.